4
Changes in Ownership
Aldeyra Therapeutics, Inc. Filed Acc 0000899243-19-023317
President and CEO bought 20,000 shares at an average $5.14 ($102,824)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Brady Todd C President and CEO | 2019-09-09 | Purchase | +10,000 | $4.89 | $48,887 | 568,991 | D |
| Brady Todd C President and CEO | 2019-09-10 | Purchase | +10,000 | $5.39 | $53,937 | 578,991 | D |
| Open-market purchases · 20,000 sh · avg $5.14 · $102,824 | |||||||
Loading xslF345X03/doc4.xml…